Woodline Partners’s Qiagen QGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-185,018
Closed -$7.41M 1124
2026
Q1
$7.41M Buy
+185,018
New +$8.76M 0.03% 584
2024
Q3
Sell
-347,572
Closed -$14.7M 687
2024
Q2
$14.7M Buy
347,572
+10,590
+3% +$464K 0.14% 209
2024
Q1
$14.9M Buy
336,982
+11,402
+4% +$520K 0.14% 206
2023
Q4
$15M Buy
325,580
+162,866
+100% +$6.93M 0.16% 184
2023
Q3
$6.99M Buy
162,714
+85,030
+109% +$3.96M 0.08% 263
2023
Q2
$3.71M Buy
77,684
+55,744
+254% +$2.69M 0.04% 340
2023
Q1
$1.07M Buy
+21,940
New +$1.12M 0.01% 466

Other funds holding QGEN

Woodline Partners's QGEN Position: Q2 2026 in Review

Woodline Partners sold out of Qiagen (QGEN) in Q2 2026, closing a stake of 185,018 shares — an estimated $7.41M sold.

Woodline Partners first reported a position in QGEN in Q1 2023 and held it in 7 quarters. The position peaked at $15M in Q4 2023. 336 funds tracked by Wall St. Rank hold QGEN as of Q2 2026.

  • Woodline Partners reported no remaining Qiagen position as of Q2 2026 after selling out during the quarter.
  • Woodline Partners sold 185,018 Qiagen shares in Q2 2026, an estimated $7.41M.
  • Woodline Partners first reported a position in Qiagen in Q1 2023 and held it in 7 quarters.
  • Woodline Partners's Qiagen position peaked at $15M in Q4 2023.
  • 336 funds tracked by Wall St. Rank held Qiagen as of Q2 2026.

Based on Woodline Partners's 13F filing for Q2 2026, filed 14 Aug 2026.